| Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma : a case report | Haematologica |  | | 2026 | 11 | 45 |
|
| Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland | Swiss medical weekly | | | 2025 | 3 | 3 |
|
| Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network | Swiss medical weekly | | | 2025 | 3 | 14 |
|
| Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia : a case report | Frontiers in immunology | | | 2024 | 44 | 162 |
|
| Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case report | Frontiers in immunology | | | 2024 | 63 | 162 |
|
| How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? | Hematological oncology | | | 2024 | 117 | 216 |
|
| Low plasma levels of hyaluronic acid might rule out sinusoidal obstruction syndrome after hematopoietic stem cell transplantation | Disease markers | | | 2023 | 87 | 187 |
|
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | | | 2022 | 141 | 374 |
|
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation |  | | 2021 | 354 | 0 |
|
| Le myélome multiple chez la personne âgée : impact d'une évaluation gériatrique | Revue médicale suisse | | | 2019 | 710 | 508 |
|
